The downfall of a maker of a constipation drug is a cautionary tale for fledgling pharma companies and their investors.
Business, Washington Post: Business
Wed, 12/12/2018 - 11:21am
The downfall of a maker of a constipation drug is a cautionary tale for fledgling pharma companies and their investors.